gptkbp:instance_of
|
gptkb:Company
|
gptkbp:acquisition
|
acquired by United Therapeutics Corporation
|
gptkbp:clinical_trial
|
xenotransplantation trials
|
gptkbp:collaborations
|
scientific research institutions
with various universities
|
gptkbp:focus
|
xenotransplantation
|
gptkbp:founded
|
gptkb:2000
|
gptkbp:founder
|
gptkb:Dr._John_A._Mc_Donald
|
gptkbp:goal
|
develop pig organs for human transplantation
|
gptkbp:headquarters
|
gptkb:Huntsville,_Alabama
|
https://www.w3.org/2000/01/rdf-schema#label
|
Revivicor
|
gptkbp:impact
|
organ transplant field
|
gptkbp:innovation
|
biomedical advancements
|
gptkbp:invention
|
biotechnology patents
|
gptkbp:leadership
|
experienced biotech executives
|
gptkbp:mission
|
address organ shortage crisis
|
gptkbp:partnership
|
gptkb:University_of_Alabama_at_Birmingham
|
gptkbp:products
|
genetically modified pigs
|
gptkbp:publishes
|
gptkb:academic_journal
|
gptkbp:receives_funding_from
|
venture capital investments
|
gptkbp:regulatory_compliance
|
FDA approval process
|
gptkbp:research_areas
|
transplant immunology
|
gptkbp:technology
|
genetic engineering
|
gptkbp:vision
|
transform organ transplantation
|
gptkbp:bfsParent
|
gptkb:United_Therapeutics_Corporation
|
gptkbp:bfsLayer
|
6
|